electroCore, Inc. (ECOR)
Makes handheld devices that stimulate your vagus nerve to treat migraines and chronic pain.
$6.09+0.01%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-10.0%
The outlook
ECOR is trading near the lower end of its 52-week range, well below both its 50- and 200-day moving averages, reflecting a bearish near-term trend. Analyst coverage leans bullish on valuation, with an average price target suggesting significant upside from current levels, though sentiment overall scores weakly bearish. The stock remains volatile relative to its recent history.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range30% of the way from its 52-week low to high
Price targetAvg target +221% vs current price
Analyst price target
~12-month · 5 analysts$19.57average target+221.3% vs now
Now $6.09
Low $12.00High $26.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$50.5M
52-wk high
$10.50
52-wk low
$4.16
50-day avg
$7.80
200-day avg
$6.35
Trailing P/E
—